mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
9e-05 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0002 |